Welcome to the Cancer Therapy & Research Center's (CTRC) Institute for Drug Development (IDD). The mission of the IDD is to develop new treatments for patients with cancer through integration of research programs of excellence in the translational and clinical sciences.
The IDD has set unprecedented standards for the development of anti-cancer agents, playing a key role in the preclinical and clinical development of 20 new cancer drugs that were subsequently approved by the Food and Drug Administration. In 2011, the IDD opened 11 first-in-human Phase I studies where we also enrolled the very first patient into each of these important studies. Having spent time in both the pharmaceutical industry as well as in academia and having successfully written multiple Investigational New Drug applications (IND) and a New Drug Application (NDA) I understand how important your drug and timelines are to you. To learn more about our organization, please continue your visit as my guest.
Steve Weitman, MD, PhD
Director, Institute For Drug Development
AT&T Distinguished Chair of Drug Development
University of Texas Health Science Center at San Antonio
7979 Wurzbach Road, Room Z459
San Antonio, Texas 78229